Semechkin Andrey 4
4 · International Stem Cell CORP · Filed Feb 22, 2018
Insider Transaction Report
Form 4
International Stem Cell CORPISCO.OB
Semechkin Andrei
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Common Stock
2018-02-20$1.09/sh+30,556$33,306→ 3,419,816 total - Exercise/Conversion
Stock Options (Right to Buy)
2018-02-20−15,556→ 54,444 totalExercise: $1.10Exp: 2027-05-31→ Common Stock (54,444 underlying) - Exercise/Conversion
Common Stock
2018-02-20$1.10/sh+15,556$17,112→ 3,435,372 total - Exercise/Conversion
Stock Options (Right to Buy)
2018-02-20−30,556→ 69,444 totalExercise: $1.09Exp: 2027-02-10→ Common Stock (69,444 underlying)
Footnotes (2)
- [F1]3/36th of the shares underlying such options shall vest on May 10, 2017, and the remaining share in equal monthly installments over a period of 33 months.
- [F2]3/36th of the shares underlying such options shall vest on August 31, 2017, and the remaining share in equal monthly installments over a period of 33 months.